Li, Z., P. Felicia, B. Li, S. Liu, and Z. Qin. Crosstalk between T cells and innate
immune cells is crucial for IFN?dependent tumor rejection. 2007, J Immunol; 179(3):1568-76.
Zhao, X., M. Mohaupt, J. Jiang, S. Liu, B. Li, and Z. Qin. Tumor Necrosis Factor
Receptor-2-Mediated Tumor Suppression is Nitric Oxide Dependent and Involves Angiostasis.
2007. Cancer Res; 67(9):4443-50.
Qin Z & Blankenstein T. A cancer immunosurveillance
controversy. NAT IMMUNOL 5,3-5 (2004).
Qin Z, Schwartzkopff J, Pradera F, Kammertoens
T, Seliger B, Pircher H & Blankenstein T. A critical requirement of
interferon gamma-mediated angiostasis for tumor rejection by CD8+
T cells. CANCER RES 63,4095 (2003).
Qin Z, Kim HJ, Hemme J & Blankenstein
T. Inhibition of methylcholanthrene-induced carcinogenesis by an interferon
gamma receptor-dependent foreign body reaction. J
EXP MED 195, 1479-1490 (2002).
Qin Z & Blankenstein T. CD4+ T cell--mediated
tumor rejection involves inhibition of angiogenesis that is dependent
on IFN gamma receptor expression by nonhematopoietic cells. Immunity
12, 677-686 (2000).
Qin Z, Richter G, Schuler T, Ibe S,
Cao X & Blankenstein T. B cells inhibit induction of T cell-dependent
tumor immunity. NAT MED 4, 627-630 (1998).